4.8 Article

Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

C. Frank Bennett et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)

Article Biochemistry & Molecular Biology

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

Matthew E. R. Butchbach et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

Markus Riessland et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery

Adam K. Bevan et al.

HUMAN MOLECULAR GENETICS (2010)

Review Biochemistry & Molecular Biology

Spinal muscular atrophy: mechanisms and therapeutic strategies

Christian L. Lorson et al.

HUMAN MOLECULAR GENETICS (2010)

Article Medicine, Research & Experimental

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy

Marco A. Passini et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Neurosciences

Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy

Tristan H. Coady et al.

JOURNAL OF NEUROSCIENCE (2010)

Article Biotechnology & Applied Microbiology

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2010)

Article Cell Biology

Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy

Chiara F. Valori et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Article Biochemistry & Molecular Biology

Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model

Virginia B. Mattis et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biotechnology & Applied Microbiology

Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons

Sandra Duque et al.

MOLECULAR THERAPY (2009)

Article Multidisciplinary Sciences

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

Kathryn J. Swoboda et al.

PLOS ONE (2009)

Article Cell Biology

Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy

Michelle L. Hastings et al.

SCIENCE TRANSLATIONAL MEDICINE (2009)

Article Genetics & Heredity

Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice

Yimin Hua et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2008)

Article Clinical Neurology

Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition

Heather L. Narver et al.

ANNALS OF NEUROLOGY (2008)

Article Medicine, Research & Experimental

Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy

Stefania Corti et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Genetics & Heredity

Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice

Li-Kai Tsai et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2008)

Review Clinical Neurology

Spinal muscular atrophy

Maryam Oskoui et al.

NEUROTHERAPEUTICS (2008)

Article Genetics & Heredity

Congenital heart disease is a feature of severe infantile spinal muscular atrophy

S. Rudnik-Schoeneborn et al.

JOURNAL OF MEDICAL GENETICS (2008)

Article Clinical Neurology

Molecular mechanisms of spinal muscular atrophy

Charlotte J. Sumner

JOURNAL OF CHILD NEUROLOGY (2007)

Article Neurosciences

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy

Matthew E. R. Butchbach et al.

NEUROBIOLOGY OF DISEASE (2007)

Article Rehabilitation

Medical considerations of long-term survival of Werdnig-Hoffmann disease

John R. Bach

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2007)

Article Biochemistry & Molecular Biology

Enhancement of SMN2 Exon 7 inclusion by antisense oligonucleotides targeting the exon

Yimin Hua et al.

PLOS BIOLOGY (2007)

Article Medicine, Research & Experimental

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

Amy M. Avila et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes

Natalia N. Singh et al.

NUCLEIC ACIDS RESEARCH (2007)

Article Medicine, Research & Experimental

Antisense oligonucleotide therapy for neurodegenerative disease

Richard A. Smith et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Clinical Neurology

Autonomic dysfunction in cases of spinal muscular atrophy type 1 with long survival

Y Hachiya et al.

BRAIN & DEVELOPMENT (2005)

Article Medicine, Research & Experimental

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

M Azzouz et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Genetics & Heredity

Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2

TW Prior et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)